ResMed Aktie
206,10
EUR
-1,20
EUR
-0,58
%
245,72
USD
-13,81
USD
-5,32
%
Werbung
ResMed Aktie Analyse
| 25.09.17 | ResMed Underweight | Barclays Capital | |
| 07.04.16 | ResMed Underweight | Barclays Capital | |
| 27.01.15 | ResMed Under Perform | Northland Capital |
Werbung
Werbung